Reanalysis of study of pancreatic effects of incretin therapy: methodological deficiencies
Author:
Affiliation:
1. Joslin Diabetes Center, Department of Medicine; Harvard Medical School; Boston MA USA
2. Department of Pathology, Diabetes Research Center and JDRF Center for Beta Cell Therapy in Diabetes; Vrije Universiteit Brussel; Brussels Belgium
Funder
National Institute of Diabetes and Digestive and Kidney Diseases
Juvenile Diabetes Research Foundation International
Publisher
Wiley
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12257/fullpdf
Reference20 articles.
1. Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors;Butler;Diabetes,2013
2. Network for pancreatic organ donors with diabetes (nPOD): developing a tissue biobank for type 1 diabetes;Campbell-Thompson;Diabetes Metab Res Rev,2012
3. Has pancreatic damage from glucagon suppressing diabetes drugs been underplayed?;Cohen;BMJ,2013
4. Incretin action in the pancreas: potential promise, possible perils, and pathological pitfalls;Drucker;Diabetes,2013
5. Incretin therapy and islet pathology: a time for caution;Kahn;Diabetes,2013
Cited by 45 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Abnormalities of Insulin Secretion and β‐Cell Defects in Type 2 Diabetes;Textbook of Diabetes;2024-01-12
2. Incretin based therapy and pancreatic cancer: Realising the reality;World Journal of Gastroenterology;2022-07-07
3. Revisiting Regulators of Human β-cell Mass to Achieve β-cell–centric Approach Toward Type 2 Diabetes;Journal of the Endocrine Society;2021-07-19
4. Incretin-based therapy and pancreatitis: accumulating evidence and unresolved questions;Annals of Translational Medicine;2018-04
5. A comparative safety review between GLP-1 receptor agonists and SGLT2 inhibitors for diabetes treatment;Expert Opinion on Drug Safety;2018-01-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3